ClinConnect ClinConnect Logo
Search / Trial NCT01958762

Screening for Cancers in the Oral CAvity

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Oct 7, 2013

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Screening Cancer Tobacco General Practitioner Precancerous Lesion Dysplasia Tobacco Vendor

ClinConnect Summary

This clinical trial is focused on finding oral cavity cancers, which are cancers that can occur in the mouth, among smokers aged 30 to 75 in the Somme region of France. The goal is to improve early detection since many people with oral cavity cancers are diagnosed too late, making treatment more difficult. The researchers aim to encourage general practitioners to screen for these cancers by using local resources like tobacco shops and community media to reach potential participants.

To be eligible for this study, participants must be smokers who buy cigarettes from local shops in the Somme area and must live in that region. There are no specific exclusions listed, making it easier for many to participate. If you join this trial, you can expect to be part of a program that aims to catch oral cancers early, ultimately helping improve health outcomes for smokers in your community. This is an important step in addressing the rising rates of oral cancer in the area.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme
  • lives in somme departement
  • Exclusion Criteria:
  • -

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, Picardie, France

Patients applied

0 patients applied

Trial Officials

Bernard DEVAUCHELLE, MD, phD

Principal Investigator

Amiens University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials